Therapie des Erysipels in Deutschland und Österreich – Ergebnisse einer Umfrage an deutschen und österreichischen Hautkliniken

Brennecke, Shaun P.; Hartmann, Martin; Schöfer, Helmut; Rasokat, H.; Tschachler, Erwin; Brockmeyer, N H

doi:10.1111/j.1610-0387.2005.04799.x

Cited by 6 publications

(3 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is no data available that demonstrates, how many patients with cellulitis of the upper extremity receive prophylactic anticoagulation. A study performed by Brennecke et al [25]. showed that prophylactic anticoagulation is applied only to 38 to 45 % of all patients with cellulitis.…”

Section: Discussionmentioning

confidence: 99%

Concomitant Venous Thrombosis in Cellulitis of the Upper Extremity

Gawaz,

Gonser,

Walter

et al. 2023

Phlebologie

View full text Add to dashboard Cite

Objectives Concurrent thrombosis is observed in up to 15 % of the patients with cellulitis of the lower extremity. The risk of concomitant venous thrombosis in patients with upper extremity cellulitis has not been investigated, yet. Aim of this study is to examine the frequency of concomitant venous thrombosis in patients with cellulitis of the upper extremity and to identify risk factors, comorbidities, and complications. Materials and Methods From 2014 to 2021, patients with cellulitis of the arm that received duplexsonography of the same limb were included. Files were reviewed for demographic data, comorbidities, and risk factors. Results 53 patients with upper limb cellulitis were included. In 11.3 % of the patients (n = 6), concomitant venous thrombosis of the upper extremity was detected. Three patients had deep arm thrombosis (brachial and subclavian veins), three had superficial vein thrombosis. Conclusion Cellulitis may increase the risk for venous thrombosis. Venous catheters and chronic lymphedema favor the occurrence of both cellulitis and venous thrombosis. Oncological patients are at particular risk for developing concomitant venous thrombosis.

show abstract

Section: Discussionmentioning

confidence: 99%

Concomitant Venous Thrombosis in Cellulitis of the Upper Extremity

Gawaz,

Gonser,

Walter

et al. 2023

Phlebologie

View full text Add to dashboard Cite

show abstract

“…None of the centers was a referral center for erysipelas, thus being representative of the population they service. Patients described in our study were seen during the clinical routine, and erysipelas was diagnosed by a dermatologist based on established clinical and laboratory criteria [3,8,9]. All relevant demographic, clinical and therapy-related parameters and laboratory signs of inflammation of patients with erysipelas on the thighs or buttocks were entered in a database.…”

Section: Methodsmentioning

confidence: 99%

“…Direct detection of the etiological agent and serology are not helpful in clinical routine [3,6,7]. Treatment with β-lactam antibiotics is sufficient in most cases [8]. The development and course of erysipelas is associated with systemic and/or local risk factors.…”

Section: Introductionmentioning

confidence: 99%

Erysipelas of the Thigh and the Gluteal Region: Retrospective Multicenter Analysis of a Very Rare Entity in 39 Patients

et al. 2012

View full text Add to dashboard Cite

Background: Erysipelas of the thigh and the gluteal region are rarely described and not well characterized. Therefore we aim to describe the prevalence, clinical characteristics, and risk factors of these erysipelas types. Methods: The files of 1,423 patients with erysipelas were analyzed. Data from patients with erysipelas of the thigh or the gluteal region were compared between the two groups and with a control group with erysipelas of the lower leg. Results: The thigh was exclusively affected in 2.1%, and the gluteal region in 0.6% of erysipelas patients. Gluteal erysipelas had conspicuous irregular borders and sometimes appeared bilaterally. Major risk factors for erysipelas of both sites were previous surgical interventions. Gluteal erysipelas was common in patients with the metabolic syndrome and required a more intense antibiotic therapy. Conclusion: Erysipelas of the thigh and the gluteal region are rare and significantly associated with prior surgical disruption of lymphatic vessels.

show abstract

Diagnostik und Therapie des Erysipels: Ein Positionspapier der Initiative Chronische Wunden (ICW) e. V.

Kröger

Schwarzkopf²,

Eder

et al. 2021

Dtsch Med Wochenschr

View full text Add to dashboard Cite

ZusammenfassungDas Erysipel ist eine bakterielle Weichgewebeinfektion, die durch β-hämolysierende Streptokokken verursacht wird und sich entlang der Lymphspalten der Haut nach proximal ausbreitet. Die Eintrittspforten der Erreger können kleinere Verletzungen oder auch chronische Wunden sein. Die Diagnose Erysipel wird klinisch durch die sich ausbreitende Rötung und Überwärmung der Haut, den reduzierten Allgemeinzustand mit Fieber und Schüttelfrost sowie mittels serologischer Entzündungsparameter gestellt und muss von zahlreichen Differenzialdiagnosen abgegrenzt werden. Die systemische Therapie erfolgt meist mit Penicillin. In der Lokaltherapie ist der Stellenwert der Maßnahmen wie Kompressionstherapie oder Kühlung derzeit noch umstritten. Insbesondere für die Rezidivprophylaxe sind die langfristige Therapie des Lymphödems sowie die konsequente Vermeidung und Therapie von Eintrittspforten essenziell.

show abstract

Therapie des Erysipels in Deutschland und Österreich – Ergebnisse einer Umfrage an deutschen und österreichischen Hautkliniken

Cited by 6 publications

References 21 publications

Concomitant Venous Thrombosis in Cellulitis of the Upper Extremity

Concomitant Venous Thrombosis in Cellulitis of the Upper Extremity

Erysipelas of the Thigh and the Gluteal Region: Retrospective Multicenter Analysis of a Very Rare Entity in 39 Patients

Diagnostik und Therapie des Erysipels: Ein Positionspapier der Initiative Chronische Wunden (ICW) e. V.

Contact Info

Product

Resources

About